Cargando…
Detection of SARS‐CoV‐2‐independent immunoregulatory activity of COVID‐19 convalescent plasma
BACKGROUND: Convalescent plasma has emerged as a potential specific treatment for coronavirus disease 2019 (COVID‐19), since it contains severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) antibodies. Several studies are currently investigating the efficacy of convalescent plasma for treatm...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662056/ https://www.ncbi.nlm.nih.gov/pubmed/34546583 http://dx.doi.org/10.1111/trf.16685 |